Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 26 | 2023 | 1320 | 2.370 |
Why?
|
| Brain | 24 | 2023 | 1203 | 2.070 |
Why?
|
| Transcriptome | 9 | 2023 | 53 | 1.650 |
Why?
|
| Gene Regulatory Networks | 6 | 2020 | 19 | 1.320 |
Why?
|
| Proteomics | 6 | 2022 | 58 | 1.100 |
Why?
|
| Cognitive Dysfunction | 12 | 2022 | 737 | 1.100 |
Why?
|
| Algorithms | 4 | 2023 | 304 | 1.060 |
Why?
|
| Gene Expression Profiling | 4 | 2023 | 108 | 1.050 |
Why?
|
| Proteome | 3 | 2022 | 23 | 0.900 |
Why?
|
| RNA, Messenger | 3 | 2022 | 283 | 0.880 |
Why?
|
| Cluster Analysis | 2 | 2023 | 38 | 0.670 |
Why?
|
| Dementia | 2 | 2022 | 388 | 0.660 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 226 | 0.650 |
Why?
|
| Nerve Net | 2 | 2019 | 34 | 0.640 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2023 | 263 | 0.630 |
Why?
|
| Humans | 43 | 2023 | 22932 | 0.540 |
Why?
|
| Aging | 8 | 2023 | 1102 | 0.520 |
Why?
|
| Genome-Wide Association Study | 6 | 2023 | 152 | 0.510 |
Why?
|
| Aged, 80 and over | 17 | 2022 | 3729 | 0.500 |
Why?
|
| Models, Neurological | 1 | 2016 | 19 | 0.490 |
Why?
|
| Models, Theoretical | 1 | 2015 | 76 | 0.460 |
Why?
|
| DNA Methylation | 5 | 2022 | 129 | 0.450 |
Why?
|
| Transcription, Genetic | 2 | 2020 | 95 | 0.440 |
Why?
|
| Foot Deformities | 1 | 2014 | 1 | 0.440 |
Why?
|
| Myofascial Pain Syndromes | 1 | 2014 | 1 | 0.440 |
Why?
|
| Pyridoxal Phosphate | 1 | 2014 | 1 | 0.440 |
Why?
|
| Quantitative Trait Loci | 5 | 2021 | 26 | 0.430 |
Why?
|
| Cognition | 6 | 2021 | 948 | 0.430 |
Why?
|
| Gene Expression | 5 | 2023 | 178 | 0.430 |
Why?
|
| Aged | 19 | 2023 | 7449 | 0.410 |
Why?
|
| Microglia | 5 | 2023 | 107 | 0.400 |
Why?
|
| Genome, Human | 3 | 2018 | 34 | 0.390 |
Why?
|
| Nervous System Diseases | 1 | 2013 | 99 | 0.380 |
Why?
|
| Male | 22 | 2022 | 12460 | 0.370 |
Why?
|
| Cerebral Cortex | 3 | 2019 | 125 | 0.360 |
Why?
|
| Female | 21 | 2022 | 12958 | 0.350 |
Why?
|
| Genotype | 4 | 2019 | 248 | 0.350 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 3 | 2019 | 21 | 0.340 |
Why?
|
| Depressive Disorder, Major | 2 | 2010 | 88 | 0.320 |
Why?
|
| Hormones | 1 | 2010 | 14 | 0.320 |
Why?
|
| Amyloid beta-Peptides | 6 | 2021 | 198 | 0.320 |
Why?
|
| Autopsy | 6 | 2019 | 255 | 0.310 |
Why?
|
| Cohort Studies | 8 | 2020 | 1417 | 0.290 |
Why?
|
| Epigenesis, Genetic | 3 | 2022 | 60 | 0.290 |
Why?
|
| Apolipoprotein E4 | 3 | 2019 | 172 | 0.280 |
Why?
|
| Membrane Transport Proteins | 2 | 2017 | 38 | 0.260 |
Why?
|
| Motor Activity | 2 | 2019 | 267 | 0.250 |
Why?
|
| Sequence Analysis, RNA | 3 | 2020 | 25 | 0.240 |
Why?
|
| Phenotype | 4 | 2023 | 260 | 0.230 |
Why?
|
| Benchmarking | 1 | 2023 | 28 | 0.200 |
Why?
|
| Apolipoproteins E | 3 | 2020 | 142 | 0.200 |
Why?
|
| Prefrontal Cortex | 2 | 2021 | 103 | 0.200 |
Why?
|
| Multifactorial Inheritance | 2 | 2019 | 12 | 0.190 |
Why?
|
| HSP27 Heat-Shock Proteins | 2 | 2019 | 14 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 116 | 0.190 |
Why?
|
| Genetic Association Studies | 2 | 2019 | 56 | 0.190 |
Why?
|
| Mutation | 2 | 2014 | 330 | 0.180 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 14 | 0.180 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 24 | 0.180 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2020 | 83 | 0.180 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 3 | 0.180 |
Why?
|
| Astrocytes | 2 | 2020 | 126 | 0.180 |
Why?
|
| Neurons | 4 | 2021 | 273 | 0.180 |
Why?
|
| Membrane Proteins | 2 | 2020 | 140 | 0.170 |
Why?
|
| Neurofibrillary Tangles | 2 | 2019 | 117 | 0.170 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 14 | 0.170 |
Why?
|
| Haplotypes | 2 | 2020 | 40 | 0.170 |
Why?
|
| Models, Genetic | 3 | 2020 | 31 | 0.170 |
Why?
|
| Movement Disorders | 1 | 2021 | 57 | 0.170 |
Why?
|
| Peptides | 1 | 2021 | 89 | 0.170 |
Why?
|
| RNA Splicing Factors | 1 | 2020 | 3 | 0.160 |
Why?
|
| Cognitive Reserve | 1 | 2020 | 22 | 0.160 |
Why?
|
| Animals | 6 | 2020 | 3270 | 0.160 |
Why?
|
| Genetic Variation | 2 | 2018 | 69 | 0.160 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 155 | 0.160 |
Why?
|
| Central Nervous System Agents | 1 | 2019 | 7 | 0.160 |
Why?
|
| Drug Discovery | 1 | 2019 | 10 | 0.160 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 13 | 0.150 |
Why?
|
| Histones | 1 | 2019 | 28 | 0.150 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 5 | 0.150 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 6 | 0.150 |
Why?
|
| Independent Living | 2 | 2019 | 225 | 0.150 |
Why?
|
| Schizophrenia | 3 | 2018 | 46 | 0.150 |
Why?
|
| Neuroimaging | 1 | 2019 | 100 | 0.150 |
Why?
|
| Seasons | 1 | 2018 | 18 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 8 | 0.140 |
Why?
|
| Frontal Lobe | 1 | 2018 | 57 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 860 | 0.140 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2019 | 94 | 0.140 |
Why?
|
| Risk Factors | 6 | 2019 | 1971 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 99 | 0.130 |
Why?
|
| Brain Infarction | 1 | 2017 | 63 | 0.130 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 228 | 0.130 |
Why?
|
| Apolipoprotein E3 | 1 | 2017 | 8 | 0.130 |
Why?
|
| Homozygote | 1 | 2017 | 13 | 0.130 |
Why?
|
| Postural Balance | 1 | 2018 | 103 | 0.130 |
Why?
|
| Lewy Bodies | 4 | 2019 | 146 | 0.130 |
Why?
|
| Inflammation | 1 | 2018 | 227 | 0.130 |
Why?
|
| Myelin Sheath | 2 | 2020 | 22 | 0.120 |
Why?
|
| Neuropsychological Tests | 4 | 2019 | 865 | 0.120 |
Why?
|
| Exercise | 1 | 2019 | 392 | 0.110 |
Why?
|
| tau Proteins | 3 | 2021 | 145 | 0.110 |
Why?
|
| Schiff Bases | 1 | 2014 | 1 | 0.110 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2014 | 1 | 0.110 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 13 | 0.110 |
Why?
|
| Vitamin B 12 | 1 | 2014 | 13 | 0.110 |
Why?
|
| Mitochondria | 1 | 2014 | 55 | 0.110 |
Why?
|
| Gait | 1 | 2018 | 381 | 0.110 |
Why?
|
| Fibromyalgia | 1 | 2014 | 27 | 0.110 |
Why?
|
| Receptors, Immunologic | 1 | 2013 | 12 | 0.100 |
Why?
|
| Behavior | 1 | 2013 | 21 | 0.100 |
Why?
|
| Amygdala | 2 | 2010 | 34 | 0.100 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 47 | 0.100 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2013 | 22 | 0.100 |
Why?
|
| Mice | 4 | 2020 | 1238 | 0.090 |
Why?
|
| Linear Models | 3 | 2018 | 192 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 1046 | 0.090 |
Why?
|
| Gene Order | 1 | 2010 | 4 | 0.080 |
Why?
|
| Brain Chemistry | 1 | 2010 | 33 | 0.080 |
Why?
|
| Alleles | 2 | 2021 | 165 | 0.080 |
Why?
|
| Homeostasis | 1 | 2010 | 65 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 168 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2020 | 337 | 0.070 |
Why?
|
| Sclerosis | 2 | 2019 | 53 | 0.070 |
Why?
|
| Biomarkers | 2 | 2020 | 474 | 0.060 |
Why?
|
| Hippocampus | 2 | 2019 | 198 | 0.060 |
Why?
|
| Species Specificity | 2 | 2020 | 34 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2015 | 32 | 0.050 |
Why?
|
| Molecular Biology | 1 | 2023 | 9 | 0.050 |
Why?
|
| Meninges | 1 | 2023 | 6 | 0.050 |
Why?
|
| Base Sequence | 1 | 2023 | 99 | 0.050 |
Why?
|
| DNA | 1 | 2023 | 94 | 0.050 |
Why?
|
| Organ Size | 1 | 2023 | 87 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 526 | 0.050 |
Why?
|
| Macrophages | 1 | 2023 | 78 | 0.050 |
Why?
|
| RNA | 1 | 2022 | 28 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2 | 0.040 |
Why?
|
| Computational Biology | 1 | 2020 | 12 | 0.040 |
Why?
|
| Individuality | 1 | 2020 | 15 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2020 | 31 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2020 | 47 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 592 | 0.040 |
Why?
|
| Lysosomes | 1 | 2020 | 20 | 0.040 |
Why?
|
| Pharmacology | 1 | 2019 | 1 | 0.040 |
Why?
|
| Systems Biology | 1 | 2019 | 5 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 175 | 0.040 |
Why?
|
| Acetylation | 1 | 2019 | 12 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 85 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 7915 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 481 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 85 | 0.040 |
Why?
|
| Memory, Episodic | 1 | 2019 | 74 | 0.040 |
Why?
|
| Cognitive Aging | 1 | 2019 | 56 | 0.040 |
Why?
|
| Metabolomics | 1 | 2018 | 6 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2018 | 19 | 0.040 |
Why?
|
| Metabolome | 1 | 2018 | 9 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2018 | 9 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 9 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 30 | 0.040 |
Why?
|
| Heterozygote | 1 | 2018 | 88 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 2019 | 101 | 0.030 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 8 | 0.030 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 12 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 35 | 0.030 |
Why?
|
| Accelerometry | 1 | 2018 | 78 | 0.030 |
Why?
|
| Epigenomics | 1 | 2017 | 11 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 351 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2017 | 30 | 0.030 |
Why?
|
| Multiple Sclerosis | 1 | 2018 | 77 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2018 | 171 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2018 | 158 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 5 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 99 | 0.030 |
Why?
|
| Adult | 2 | 2023 | 6931 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 66 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1493 | 0.030 |
Why?
|
| Chicago | 1 | 2019 | 813 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 309 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 761 | 0.030 |
Why?
|
| Tuberous Sclerosis | 1 | 2015 | 12 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 251 | 0.030 |
Why?
|
| Amyloid | 1 | 2015 | 37 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 43 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 30 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 48 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2015 | 109 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 387 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2018 | 692 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1412 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 45 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2018 | 591 | 0.020 |
Why?
|
| United States | 1 | 2017 | 1765 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2009 | 13 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 54 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 90 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2009 | 88 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 375 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2009 | 207 | 0.020 |
Why?
|